All Stories

  1. Referral Patterns, Diagnostic Delay, and Clinical Characteristics of Patients with Axial Spondyloarthritis in a Tertiary Rheumatology Centre in Malaysia: A Retrospective Observational Study
  2. A retrospective, real-world study on serious infection risk in a multiracial rheumatoid arthritis population on advanced therapies
  3. Latent profiles of kinesiophobia and associated factors in patients with rheumatoid arthritis: a cross-sectional study
  4. Ethnic Disparities in Achieving Treatment Targets and Organ Damage Accrual in Systemic Lupus Erythematosus: A Multi-Centre Study from Malaysia
  5. Adapted emotional freedom techniques (EFT) for managing kinesiophobia in patients with rheumatoid arthritis: a feasibility study
  6. Biologic of choice after secukinumab failure in psoriatic arthritis patient: Ixekizumab or interleukin-23 inhibitors – A retrospective study
  7. The APLAR Recommendations for the Management of Psoriatic Arthritis
  8. Association of Anti-Signal Recognition Particle Myopathy with Systemic Lupus Erythematosus
  9. ABS1129 DELAYED REMISSION AND DAMAGE IN A MULTI-ETHNIC MALAYSIAN SYSTEMIC LUPUS ERYTHEMATOSUS COHORT
  10. RELATIONSHIP BETWEEN AUTOANTIBODY-DEFINED SYSTEMIC LUPUS ERYTHEMATOSUS SUBGROUPS AND CLINICAL MANIFESTATIONS: PRELIMINARY FINDINGS FROM ILUPUS STUDY
  11. Defining normal enthesis stiffness range in a healthy adult population
  12. The clinical characteristics of Malaysian patients with Takayasu Arteritis: A retrospective study of 3 decades
  13. Predictive factors of psoriatic arthritis in a diverse population with psoriasis
  14. 2D shear wave elastography for the assessment of quadriceps entheses—a methodological study
  15. POS1586-HPR DOES DEVELOPING SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) MAKE A DIFFERENCE IN PATIENTS WITH UNDERLYING IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)?
  16. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients in Malaysia
  17. AB0781 Malaysia Spondylarthritis Accelerated Management (SAM) Model: Expediting AxSpA patient journey from early referral, diagnosis and access to optimal care
  18. Algorithm for the referral of patients with inflammatory back pain from primary care in Malaysia
  19. POS1075 PREDICTIVE FACTORS ASSOCIATED WITH DEVELOPMENT OF PSORIATIC ARTHRITIS IN PATIENTS WITH UNDERLYING PSORIASIS
  20. Ocular surface disease in psoriatic patients in a developing country
  21. Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE)
  22. Fatigue and associated factors in a multi‐ethnic cohort of rheumatoid arthritis patients
  23. SAT0597 EARLY DAMAGE AS MEASURED BY SLICC/ACR DAMAGE INDEX IS A PREDICTOR OF HOSPITALIZATION IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
  24. Personal experience and knowledge about psoriasis reduce misconceptions and discriminatory behavior toward people living with psoriasis in Malaysia
  25. Drug-related problems in patients with rheumatoid arthritis
  26. Pregnancy-associated osteoporosis: a UK case series and literature review
  27. Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis
  28. Conventional synthetic disease-modifying antirheumatic drug use by race/ethnicity and factors associated with initiating biologics in Malaysian patients with rheumatoid arthritis
  29. AB1341 Profile and important characteristics of rheumatological diseases managed over one year in a urban university based rheumatology clinic in kuala lumpur, malaysia
  30. Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply
  31. Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort
  32. SAT0392 The Drug Survival of Anti-Tumour Necrosis Factor (TNF) Treatment in A UK Cohort of Axial Spondyloarthritis Patients
  33. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort
  34. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement
  35. Myocardial infarction with normal coronaries: an unexpected finding in a 13-year-old girl with systemic lupus erythematosus
  36. Painless ascites and elevated CA125: initial presentation of lupus-associated protein-losing enteropathy
  37. Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus